$USNA
USANA Health Sciences Inc Stock $usna

$usna Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000143774922011874 Filed on May 11, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q2
Revenue	$272.9M	$267.3M	$308.0M
YoY Change	-11.4%	-13.91%	18.91%
Cost Of Revenue	$51.38M	$52.52M	$57.65M
YoY Change	-10.87%	-10.99%	20.93%
Gross Profit	$221.5M	$214.8M	$250.3M
YoY Change	-11.52%	-14.6%	18.46%
Gross Profit Margin	81.17%	80.35%	81.28%
Selling, General & Admin	$68.80M	$183.3M	$71.63M
YoY Change	-3.96%	-7.9%	17.66%
% of Gross Profit	31.06%	85.33%	28.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.279M	$3.282M	$3.231M
YoY Change	1.49%	2.56%	-7.69%
% of Gross Profit	1.48%	1.53%	1.29%
Operating Expenses	$188.4M	$183.3M	$206.1M
YoY Change	-8.59%	-7.9%	20.03%
Operating Profit	$33.07M	$31.51M	$44.20M
YoY Change	-25.18%	-39.99%	11.65%
Interest Expense	$32.00K	$571.0K	$5.000K
YoY Change	540.0%	-68.28%	-97.7%
% of Operating Profit	0.1%	1.81%	0.01%
Other Income/Expense, Net	$220.0K	-$430.0K	$139.0K
YoY Change	58.27%	-315.0%	-64.63%
Pretax Income	$33.29M	$31.65M	$44.34M
YoY Change	-24.92%	-41.93%	10.9%
Income Tax	$10.82M	$11.33M	$13.72M
% Of Pretax Income	32.5%	35.79%	30.93%
Net Earnings	$22.47M	$20.32M	$30.62M
YoY Change	-26.62%	-48.69%	9.45%
Net Earnings / Revenue	8.23%	7.6%	9.94%
Basic Earnings Per Share	$1.16		$1.47
Diluted Earnings Per Share	$1.15	$1.033M	$1.45
COMMON SHARES
Basic Shares Outstanding	19.35M		20.89M
Diluted Shares Outstanding	19.48M		21.10M

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$237.8M	$239.8M	$257.0M
YoY Change	-7.49%	-23.11%	13.02%
Cash & Equivalents	$237.8M	$239.8M	$257.0M
Short-Term Investments
Other Short-Term Assets	$28.45M	$3.681M	$28.60M
YoY Change	-0.52%	-25.88%	1.06%
Inventory	$97.58M	$98.32M	$87.65M
Prepaid Expenses
Receivables
Other Receivables		$5.584M
Total Short-Term Assets	$363.8M	$365.1M	$373.2M
YoY Change	-2.52%	-14.15%	14.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$100.8M	$101.8M	$98.62M
YoY Change	2.2%	1.33%	0.19%
Goodwill	$17.66M	$17.67M	$17.31M
YoY Change	2.03%	1.73%	4.78%
Intangibles	$30.12M	$30.44M	$30.35M
YoY Change	-0.73%	-1.15%	4.61%
Long-Term Investments
YoY Change
Other Assets	$56.02M	$57.89M	$59.89M
YoY Change	-6.47%	-7.15%	51.63%
Total Long-Term Assets	$209.1M	$212.6M	$211.3M
YoY Change	-1.04%	-1.38%	12.89%
TOTAL ASSETS
Total Short-Term Assets	$363.8M	$365.1M	$373.2M
Total Long-Term Assets	$209.1M	$212.6M	$211.3M
Total Assets	$572.9M	$577.7M	$584.5M
YoY Change	-1.98%	-9.85%	14.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.25M	$13.51M	$11.95M
YoY Change	-5.89%	-25.76%	9.23%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.00M
YoY Change
Total Short-Term Liabilities	$158.0M	$160.8M	$151.5M
YoY Change	4.3%	-4.33%	8.4%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$13.59M	$14.33M	$16.31M
YoY Change	-16.69%	-25.19%	-2.78%
Total Long-Term Liabilities	$13.59M	$14.33M	$16.31M
YoY Change	-16.69%	-25.19%	-2.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$158.0M	$160.8M	$151.5M
Total Long-Term Liabilities	$13.59M	$14.33M	$16.31M
Total Liabilities	$171.6M	$175.1M	$167.8M
YoY Change	2.26%	-6.47%	7.2%
SHAREHOLDERS EQUITY
Retained Earnings	$344.8M	$344.6M	$353.2M
YoY Change	-2.39%	-9.97%	12.97%
Common Stock	$45.97M	$50.03M	$54.10M
YoY Change	-15.03%	-19.93%	-2.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$389.9M	$395.1M	$402.8M
YoY Change
Total Liabilities & Shareholders Equity	$572.9M	$577.7M	$584.5M
YoY Change	-1.98%	-9.85%	14.13%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q2
OPERATING ACTIVITIES
Net Income	$22.47M	$20.32M	$30.62M
YoY Change	-26.62%	-48.69%	9.45%
Depreciation, Depletion And Amortization	$3.279M	$3.282M	$3.231M
YoY Change	1.49%	2.56%	-7.69%
Cash From Operating Activities	$19.70M	$24.92M	$19.66M
YoY Change	0.21%	-47.97%	-39.7%
INVESTING ACTIVITIES
Capital Expenditures	$1.789M	-$3.153M	$1.597M
YoY Change	12.02%	110.2%	-145.63%
Acquisitions
YoY Change
Other Investing Activities	$3.000K	$0.00	-$1.500M
YoY Change	-100.2%	-100.0%	-175.0%
Cash From Investing Activities	-$1.786M	-$3.153M	-$3.088M
YoY Change	-42.16%	-85.33%	105.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$25.38M		$67.61M
YoY Change	-62.46%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$19.59M	-32.44M	-$70.48M
YoY Change	-72.2%	8011.25%
NET CHANGE
Cash From Operating Activities	$19.70M	24.92M	$19.66M
Cash From Investing Activities	-$1.786M	-3.153M	-$3.088M
Cash From Financing Activities	-$19.59M	-32.44M	-$70.48M
Net Change In Cash	-$2.081M	-10.68M	-$55.87M
YoY Change	-96.28%	-141.06%	-279.63%
FREE CASH FLOW
Cash From Operating Activities	$19.70M	$24.92M	$19.66M
Capital Expenditures	$1.789M	-$3.153M	$1.597M
Free Cash Flow	$17.91M	$28.07M	$18.06M
YoY Change	-0.83%	-43.17%	-49.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4542000	USD
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30124000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30442000	USD
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19188123
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19185000
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19185000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19393000
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19393000
CY2022Q2	usna	Number Of Geographic Regions NumberOfGeographicRegions	2	pure
CY2022Q2	usna	Number Of Sub Geographical Regions NumberOfSubGeographicalRegions	3	pure
CY2022Q1	usna	Nonfinancial Assets Fair Value Disclosure NonfinancialAssetsFairValueDisclosure	0	USD
CY2022	usna	Equity Securities Without Readily Determinable Fair Value Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValuePriceAdjustmentCumulativeAmount	0	USD
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	USD
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	237753000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	239832000	USD
CY2022Q2	us-gaap	Inventory Net InventoryNet	97581000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	98318000	USD
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28451000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26967000	USD
CY2022Q2	us-gaap	Assets Current AssetsCurrent	363785000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	365117000	USD
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	100792000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101780000	USD
CY2022Q2	us-gaap	Goodwill Goodwill	17661000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	17668000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4839000	USD
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	56015000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	57894000	USD
CY2022Q2	us-gaap	Assets Assets	572919000	USD
CY2022Q1	us-gaap	Assets Assets	577740000	USD
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	11248000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	13508000	USD
CY2022Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	10000000	USD
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	136719000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	147282000	USD
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	157967000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	160790000	USD
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	11419000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7497000	USD
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13587000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14329000	USD
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	19000	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	19000	USD
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	45951000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	50010000	USD
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	344755000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	344637000	USD
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-779000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	458000	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	389946000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	395124000	USD
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	572919000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	577740000	USD
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	272867000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	307976000	USD
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	51383000	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	57651000	USD
CY2022Q2	us-gaap	Gross Profit GrossProfit	221484000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	250325000	USD
CY2022Q2	usna	Associate Incentives AssociateIncentives	119620000	USD
CY2021Q2	usna	Associate Incentives AssociateIncentives	134495000	USD
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	68797000	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	71633000	USD
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	188417000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	206128000	USD
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	33067000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	44197000	USD
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	739000	USD
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	760000	USD
CY2022Q2	us-gaap	Interest Expense InterestExpense	32000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	5000	USD
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-487000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-616000	USD
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	220000	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	139000	USD
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33287000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44336000	USD
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10818000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13715000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	22469000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	30621000	USD
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.47
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.45
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19351000
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20892000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19481000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21096000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	22469000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	30621000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-691000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-2531000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	546000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1616000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1237000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-915000	USD
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21232000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	29706000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	441650000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	30621000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-915000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3740000	USD
CY2021Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	69454000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2021Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2865000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	402777000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	395124000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	22469000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1237000	USD
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3183000	USD
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	25382000	USD
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4211000	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	389946000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	22469000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	30621000	USD
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3279000	USD
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3231000	USD
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2327000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2259000	USD
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3000	USD
CY2021Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-47000	USD
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3183000	USD
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3740000	USD
CY2022Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3667000	USD
CY2021Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	2968000	USD
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-48000	USD
CY2021Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1393000	USD
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1865000	USD
CY2021Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3960000	USD
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2153000	USD
CY2021Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6899000	USD
CY2022Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-11251000	USD
CY2021Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-13741000	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19701000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19659000	USD
CY2022Q2	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2021Q2	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	51000	USD
CY2022Q2	us-gaap	Payments For Hedge Investing Activities PaymentsForHedgeInvestingActivities	-0	USD
CY2021Q2	us-gaap	Payments For Hedge Investing Activities PaymentsForHedgeInvestingActivities	1555000	USD
CY2022Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000	USD
CY2021Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13000	USD
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1789000	USD
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1597000	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1786000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3088000	USD
CY2022Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25382000	USD
CY2021Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	67610000	USD
CY2022Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	10000000	USD
CY2021Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2022Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4211000	USD
CY2021Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2865000	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19593000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-70475000	USD
CY2022Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-403000	USD
CY2021Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1962000	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2081000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-55866000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	243653000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	315937000	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	241572000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	260071000	USD
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	237753000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	256964000	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	241572000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	260071000	USD
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	5000	USD
CY2021Q2	us-gaap	Interest Paid Net InterestPaidNet	3000	USD
CY2022Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	8347000	USD
CY2021Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	13523000	USD
CY2022Q2	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	25000	USD
CY2021Q2	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	0	USD
CY2022Q2	usna	Noncashrightofuseassetobtainedinexchangeforoperatingleaseliability Noncashrightofuseassetobtainedinexchangeforoperatingleaseliability	289000	USD
CY2021Q2	usna	Noncashrightofuseassetobtainedinexchangeforoperatingleaseliability Noncashrightofuseassetobtainedinexchangeforoperatingleaseliability	829000	USD
CY2022Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	285000	USD
CY2021Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	239000	USD
CY2022Q2	usna	Unsettled Trades For Repurchase Of Common Stock UnsettledTradesForRepurchaseOfCommonStock	0	USD
CY2021Q2	usna	Unsettled Trades For Repurchase Of Common Stock UnsettledTradesForRepurchaseOfCommonStock	1844000	USD
CY2022Q2	usna	Nonfinancial Assets Fair Value Disclosure NonfinancialAssetsFairValueDisclosure	0	USD
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	30591000	USD
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	30280000	USD
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9734000	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9586000	USD
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	57256000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	58452000	USD
CY2022Q2	us-gaap	Inventory Net InventoryNet	97581000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	98318000	USD
CY2022Q2	usna	Equity Securities Without Readily Determinable Fair Value Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValuePriceAdjustmentCumulativeAmount	0	USD
CY2022Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	USD
CY2022Q2	us-gaap	Other Income OtherIncome	899000	USD
CY2021Q2	us-gaap	Other Income OtherIncome	972000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	19635000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15952000	USD
CY2022Q2	usna	Contract With Customer Liability Increase Decrease In Deferred Revenue ContractWithCustomerLiabilityIncreaseDecreaseInDeferredRevenue	17183000	USD
CY2022Q1	usna	Contract With Customer Liability Increase Decrease In Deferred Revenue ContractWithCustomerLiabilityIncreaseDecreaseInDeferredRevenue	19635000	USD
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	15939000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	15952000	USD
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20879000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	19635000	USD
CY2022Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	98930000	USD
CY2021Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	98684000	USD
CY2022Q2	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	470000	USD
CY2021Q2	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	190000	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30621000	USD
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19351000
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	22469000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20892000
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	130000
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	204000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19481000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21096000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.47
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.45
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	170000
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57000
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	288000
CY2021Q2	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	721000
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	25382000	USD
CY2021Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	69454000	USD
CY2022Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	82839000	USD
CY2022Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	272867000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	307976000	USD

Files In Submission

Name	View Source	Status
0001437749-22-011874-index-headers.html	Edgar Link	pending
0001437749-22-011874-index.html	Edgar Link	pending
0001437749-22-011874.txt	Edgar Link	pending
0001437749-22-011874-xbrl.zip	Edgar Link	pending
ex_349392.htm	Edgar Link	pending
ex_349393.htm	Edgar Link	pending
ex_349394.htm	Edgar Link	pending
ex_349395.htm	Edgar Link	pending
ex_372153.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
usna-20220402.xsd	Edgar Link	pending
usna-20220402_cal.xml	Edgar Link	unprocessable
usna-20220402_def.xml	Edgar Link	unprocessable
usna-20220402_lab.xml	Edgar Link	unprocessable
usna-20220402_pre.xml	Edgar Link	unprocessable
usna20220321_10q.htm	Edgar Link	pending
usna20220321_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$USNA
USANA Health Sciences Inc Stock $usna

2022 Q2 Form 10-Q Financial Statement

#000143774922011874 Filed on May 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USNA USANA Health Sciences Inc Stock $usna

2022 Q2 Form 10-Q Financial Statement

#000143774922011874 Filed on May 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USNA
USANA Health Sciences Inc Stock $usna